Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

Aim. To demonstrate diagnostic and prognostic significance of series measurement of WT1 expression in patients with acute myeloid leukemia (AML) after allogenic hematopoietic stem cell transplantation (allo-HSCT). Materials & Methods. The clinical trial included 88 AML patients (38 females (4...

Full description

Bibliographic Details
Main Authors:	YaV Gudozhnikova, NN Mamaev, IM Barkhatov, VA Katerina, TL Gindina, AI Shakirova, SN Bondarenko, OA Slesarchuk, EI Darskaya, OV Paina, LS Zubarovskaya, BV Afanas’ev
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2018-07-01
Series:	Kliničeskaâ onkogematologiâ
Subjects:	acute myeloid leukemia allo-HSCT posttransplant relapse diagnostics and treatment with molecular monitoring of WT1 expression graft vs. host disease
Online Access:	http://bloodjournal.ru/wp-content/uploads/2018/06/5.pdf

Similar Items

Results of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia with t(8;21)(q22;q22)/RUNX1-RUNX1T1 and Additional Cytogenetic Abnormalities
by: TL Gindina, et al.
Published: (2016-04-01)

Achievements and Challenges in Allogeneic Hematopoietic Stem Cell Transplantation in Cytogenetically Unfavorable Acute Leukemias (Literature Review)
by: NN Mamaev, et al.
Published: (2019-03-01)

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
by: MV Barabanshchikova, et al.
Published: (2016-07-01)

Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors
by: EV Morozova, et al.
Published: (2019-03-01)

Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis
by: M. V. Barabanshchikova, et al.
Published: (2016-03-01)

Crucial Role of BAALC-Expressing Progenitor Cells in Emergence and Development of Post-Transplantation Relapses in Patients with Acute Myeloid Leukemia
by: NN Mamaev, et al.
Published: (2019-12-01)

Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults
by: TL Gindina, et al.
Published: (2017-07-01)

Efficacy of Chemotherapy in Acute Leukemia Patients Resistant to Previous Standard Treatment According to the Series Measurement of WT1 Gene Expression
by: NN Mamaev, et al.
Published: (2018-01-01)

WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review)
by: NN Mamaev, et al.
Published: (2016-07-01)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
by: Nadira Duraković, et al.
Published: (2021-07-01)

A case of posttransplant lymphoproliferative disorder
by: G S Chowdhary, et al.
Published: (2017-01-01)

Low pre-transplant levels of mannose-binding lectin are associated with viral infections and mortality after haematopoietic allogeneic stem cell transplantation
by: M. Puente, et al.
Published: (2019-11-01)

Early posttransplant granulomatous interstitial nephritis
by: Sriram Sriperumbuduri, et al.
Published: (2017-01-01)

Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome
by: Hiroki Hosoi, et al.
Published: (2018-09-01)

High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
by: Zhang G, et al.
Published: (2019-04-01)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
by: Lv Meng, et al.
Published: (2012-03-01)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
by: Ariadna Bartoló-Ibars, et al.
Published: (2021-09-01)

Posttransplant vesical calculi – A case series
by: Dimple Kumar Chanamolu, et al.
Published: (2019-01-01)

IMPACT OF HLA-DPB1 INCOMPATIBILITY ON THE RESULTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM HLA-A-B-C–DRB1-DQB1-COMPATIBLE UNRELATED DONOR
by: E. G. Khamaganova, et al.
Published: (2018-05-01)

Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide
by: OV Pirogova, et al.
Published: (2016-10-01)

Posttransplant lymphoproliferative disorder: Experience from a pediatric nephrology unit in North India
by: R W Thergaonkar, et al.
Published: (2018-01-01)

Posttransplant lymphoproliferative disorder coexisting with extrapulmonary tuberculosis: A diagnostic dilemma
by: Mohammed Shoeb Ahmed Khan, et al.
Published: (2018-01-01)

The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia
by: Caixia Han, et al.
Published: (2021-02-01)

Immunotherapy in Myeloproliferative Diseases
by: Lukas M. Braun, et al.
Published: (2020-06-01)

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
by: Huihui Zhang, et al.
Published: (2019-04-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders
by: Shahrzad Bakhtiar, et al.
Published: (2019-11-01)

Peripheral blood lymphocyte responses to cytomegalovirus seropositivity after allogeneic-hematopoietic stem cell transplantation
by: Zhang J, et al.
Published: (2018-08-01)

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
by: Nancy Y. Villa, et al.
Published: (2016-03-01)

Cytomegalovirus pneumonitis complicated by a central peribronchial pattern of organising pneumonia
by: Maria M. Cuadrado, et al.
Published: (2017-01-01)

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
by: Chen Yang, et al.
Published: (2018-10-01)

High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients
by: Soumaya Kouidhi, et al.
Published: (2021-08-01)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
by: Madoka Kanda-Kato, et al.
Published: (2020-09-01)

Therapy of chronic lymphocytic leukemia (CLL) - from past to present
by: Anna Gumieniczek, et al.
Published: (2020-02-01)

Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation
by: Sabrina Basso, et al.
Published: (2020-10-01)

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
by: Mingshan Niu, et al.
Published: (2019-05-01)

Donor and Recipient Individual Factors as Predictive Markers of Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation; Dream or Reality
by: Pooya Eslampour, et al.
Published: (2021-02-01)

Prevalence and risk factors for posttransplant diabetes mellitus: Data from government tertiary care center
by: Jayanivash Jayam, et al.
Published: (2018-01-01)

Posttransplant Lymphoproliferative Disorder Involving the Gastrointestinal Tract
by: Tejas Kirtane, et al.
Published: (2020-12-01)

Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis 
by: Huang Y, et al.
Published: (2019-05-01)

Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study
by: Sarah S. Alghanem, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_t5om6ucf62ju949g1tn4on989c